Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in QTTB — Q32 Bio Inc.

CIK 1423053 MIAMI, FL
Back to QTTB Full portfolio

Position in QTTB

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$1,537,246
+$1,437,858 QoQ
Shares Held
120,663
+679.4% QoQ
Ownership
0.405%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 71 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QTTB Over Time

Shares Held

Position Value (USD)

Derivatives in QTTB

reported options exposure · as of Jun 30, 2025
CallValue
$16,241
CallShares
10,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. QTTB ranks #211 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in QTTB

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,537,246 120,663
2026-03-31 $99,388 15,481
2025-12-31 $151,816 45,728
2025-09-30 $20,031 10,117
2025-06-30 $16,241 10,900
2024-12-31 $19,608 5,700
2024-12-31 $15,480 4,500
2024-06-30 $2,872 160
2024-06-30 $325,235 18,119
2024-03-31 $171,439 10,061
2024-03-31 $19,510 1,145